About datameds ai inc - MEDS
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
MEDS At a Glance
DataMeds AI, Inc.
3000 Bayport Drive
Tampa, Florida 33607
| Phone | 1-844-203-6092 | Revenue | 23.34M | |
| Industry | Medical Distributors | Net Income | -101,274,530.00 | |
| Sector | Distribution Services | 2025 Sales Growth | 28.733% | |
| Fiscal Year-end | 12 / 2026 | Employees | N/A | |
| View SEC Filings |
MEDS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.734 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.836 |
| Enterprise Value to Sales | 2.794 |
| Total Debt to Enterprise Value | 0.38 |
MEDS Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 20.522 |
| Total Asset Turnover | 0.532 |
MEDS Liquidity
| Current Ratio | 0.095 |
| Quick Ratio | 0.04 |
| Cash Ratio | 0.001 |
MEDS Profitability
| Gross Margin | -41.295 |
| Operating Margin | -347.91 |
| Pretax Margin | -433.95 |
| Net Margin | -433.95 |
| Return on Assets | -230.714 |
| Return on Equity | N/A |
| Return on Total Capital | -822.031 |
| Return on Invested Capital | -1,014.509 |
MEDS Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 201.037 |
| Total Debt to Total Assets | 81.314 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 106.551 |